Biote (BTMD) Common Equity (2020 - 2026)

Biote has reported Common Equity for 7 years, with the latest figure at -$48.0 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 43.47% year-over-year to -$48.0 million; the trailing twelve-month figure through Mar 2026 stood at -$48.0 million (up 43.47% YoY), and the FY2025 full-year result was -$58.5 million, up 42.72% from the prior year.
• Common Equity for Q1 2026 stood at -$48.0 million, up from -$58.5 million in the prior quarter.
• The five-year high for Common Equity was $10.7 million in Q1 2022, with the low at -$141.5 million in Q2 2024.
• Average Common Equity over 5 years is -$69.7 million, with a median of -$70.8 million recorded in 2022.
• Peak annual rise in Common Equity reached 201.52% in 2022, while the deepest fall reached 5136.29% in 2022.
• Tracing BTMD's Common Equity over 5 years: stood at -$58.3 million in 2022, then surged by 37.29% to -$36.5 million in 2023, then sank by 179.65% to -$102.2 million in 2024, then soared by 42.72% to -$58.5 million in 2025, then rose by 18.08% to -$48.0 million in 2026.
• The last three Common Equity figures came in at -$48.0 million (Q1 2026), -$58.5 million (Q4 2025), and -$65.5 million (Q3 2025), per Business Quant data.

Peer Comparison